Literature DB >> 8987361

T helper cell activation and human retroviral pathogenesis.

K F Copeland1, J L Heeney.   

Abstract

T helper (Th) cells are of central importance in regulating many critical immune effector mechanisms. The profile of cytokines produced by Th cells correlates with the type of effector cells induced during the immune response to foreign antigen. Th1 cells induce the cell-mediated immune response, while Th2 cells drive antibody production. Th cells are the preferential targets of human retroviruses. Infections with human T-cell leukemia virus (HTLV) or human immunodeficiency virus (HIV) result in the expansion of Th cells by the action of HTLV (adult T-cell leukemia) or the progressive loss of T cells by the action of HIV (AIDS). Both retrovirus infections impart a high-level activation state in the host immune cells as well as systemically. However, diverging responses to this activation state have contrasting effects on the Th-cell population. In HIV infection, Th-cell loss has been attributed to several mechanisms, including a selective elimination of cells by apoptosis. The induction of apoptosis in HIV infection is complex, with many different pathways able to induce cell death. In contrast, infection of Th cells with HTLV-1 affords the cell a protective advantage against apoptosis. This advantage may allow the cell to escape immune surveillance, providing the opportunity for the development of Th-cell cancer. In this review, we will discuss the impact of Th-cell activation and general immune activation on human retrovirus expression with a focus upon Th-cell function and the progression to disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8987361      PMCID: PMC239461          DOI: 10.1128/mr.60.4.722-742.1996

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN: 0146-0749


  365 in total

1.  HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Authors:  Y Feng; C C Broder; P E Kennedy; E A Berger
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

2.  Stimulation of the CD2 receptor pathway induces apoptosis in human T lymphotropic virus type I-infected cell lines.

Authors:  D J Guyot; O J Trask; J M Andrews; G C Newbound; M D Lairmore
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-04-01

3.  Clinical significance of CD45RO expression on peripheral blood mononuclear cells in HTLV-I-infected individuals.

Authors:  M Suzuki; H Uno; K Yamashita; T Toyama; Y Kubuki; K Maeda; H Matsuoka; S Ohtaki; H Tsubouchi
Journal:  Br J Haematol       Date:  1996-02       Impact factor: 6.998

4.  Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.

Authors:  S R Bartz; M E Rogel; M Emerman
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Vpr-induced cell cycle arrest is conserved among primate lentiviruses.

Authors:  V Planelles; J B Jowett; Q X Li; Y Xie; B Hahn; I S Chen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific.

Authors:  K F Copeland; P J McKay; K L Rosenthal
Journal:  AIDS Res Hum Retroviruses       Date:  1995-11       Impact factor: 2.205

Review 7.  Immunosuppressive retroviral peptides: cAMP and cytokine patterns.

Authors:  S Haraguchi; R A Good; N K Day
Journal:  Immunol Today       Date:  1995-12

8.  Regulation of NF-kappa B activation in T helper 1 and T helper 2 cells.

Authors:  J A Lederer; J S Liou; S Kim; N Rice; A H Lichtman
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

Review 9.  Role of apoptosis in HIV disease pathogenesis.

Authors:  N Oyaizu; S Pahwa
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

10.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  11 in total

1.  Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis.

Authors:  D Pyeon; G A Splitter
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 2.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

3.  Tetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathways.

Authors:  Mélanie R Tardif; Michel J Tremblay
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Characteristics of bursal T lymphocytes induced by infectious bursal disease virus.

Authors:  I J Kim; S K You; H Kim; H Y Yeh; J M Sharma
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum beta2microglobulin levels.

Authors:  J A García-García; J A Mira; J Fernández-Rivera; A J Ramos; J Vargas; J Macías; J A Pineda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-01       Impact factor: 3.267

6.  Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

Authors:  Eduardo Samo Gudo; Nilesh B Bhatt; Dulce Ramalho Bila; Celina Monteiro Abreu; Amílcar Tanuri; Wilson Savino; Suse Dayse Silva-Barbosa; Ilesh V Jani
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

7.  Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus.

Authors:  J Macías; J A Pineda; F Lozano; J E Corzo; A Ramos; E León; J A García-García; J Fernández-Rivera; J A Mira; J Gómez-Mateos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-23       Impact factor: 3.267

8.  Systemic Immune Activation and HIV Shedding in the Female Genital Tract.

Authors:  LaShonda Y Spencer; Shawna Christiansen; Chia-Hao H Wang; Wendy J Mack; Mary Young; Howard D Strickler; Kathryn Anastos; Howard Minkoff; Mardge Cohen; Ruth M Geenblatt; Roksana Karim; Eva Operskalski; Toni Frederick; James D Homans; Alan Landay; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2016-02-01       Impact factor: 3.731

9.  Reduced cell turnover in bovine leukemia virus-infected, persistently lymphocytotic cattle.

Authors:  Christophe Debacq; Becca Asquith; Michal Reichert; Arsène Burny; Richard Kettmann; Luc Willems
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Mineki Saito; Reiko Tanaka; Shiho Arishima; Toshio Matsuzaki; Satoshi Ishihara; Takashi Tokashiki; Yusuke Ohya; Hiroshi Takashima; Fujio Umehara; Shuji Izumo; Yuetsu Tanaka
Journal:  Retrovirology       Date:  2013-05-07       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.